Representative before the EPO

Employment test 11 - 50 employees
Company dna isenbruck bosl horschler llp
operating since 2003
Headquarter in Mannheim and 4 offices
active in Legal Services and IP Consulting

Representative before the EPO

Employment test 11 - 50 employees
Company dna herzog fiesser and partner
operating since 2010
Headquarter in Munich and 2 offices
active in Legal Services and IP Consulting

We have observed 102 EP applications Alexander Dick has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 27, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11819989

HEMOKININ-1 RECEPTOR AND HEMOKININ-1-DERIVED PEPTIDE

IPC classification:
A61P 29/00, A61P 43/00, C07K 7/06, C07K 16/28, C12N 15/113, G01N 33/15, G01N 33/50, A61K 38/00
Applicant:
University of Miyazaki
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12166013

proSP-B based diagnosis of distal airway involvement in asthma

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP11781559

USE OF INTERLEUKIN 10 MRNA TRANSFECTED MACROPHAGES IN ANTI-INFLAMMATORY THERAPIES

IPC classification:
A61P 29/00, A61K 35/14, A61K 35/26, A61K 35/28, A61K 38/20
Applicant:
Ulm University (Universität Ulm)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP11196214

Histone deacetylase 10-inhibitor co-treatment in cancer

IPC classification:
G01N 33/574, A61K 31/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION REFUSED
EP12706220

B-TYPE PLEXIN ANTAGONISTS AND USES THEREOF

IPC classification:
A61P 35/04, C07K 16/30, C12N 15/113, A61K 31/713, A61K 39/395
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP12707625

METHOD FOR THE DETERMINATION OF BOTULINUM NEUROTOXIN BIOLOGICAL ACTIVITY

IPC classification:
C12N 9/64, G01N 33/50
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP12710086

MEASUREMENT OF C-TERMINAL proSP-B

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12156192

HBV immunocomplexes for response prediction and therapy monitoring of chronic HBV patients

IPC classification:
G01N 33/576, G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION REFUSED
EP13181250

Novel fatty acid desaturases and uses thereof

IPC classification:
C12N 15/82, C12N 9/02, C12P 7/64
Applicant:
BASF Plant Science Company GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Agent:
Stephan Gerhard Krieger, BASF SE
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12774075

PLANTS HAVING ENHANCED YIELD-RELATED TRAITS AND METHOD FOR MAKING THE SAME

IPC classification:
C07K 14/415, C12N 15/29, C12N 15/63, A01H 1/00, A01H 5/00
Applicant:
BASF Plant Science Company GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12749786

ZEAXANTHIN-ENRICHED POULTRY EGG

IPC classification:
A23K 1/00, A23K 1/16, A23K 1/18, A23L 1/30, A23L 1/32
Applicant:
JX Nippon Oil & Energy Corporation
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12185337

Determination of tryptophan metabolites for assessing liver cell function

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION REFUSED
EP12726793

PREDICTION OF RECURRENCE FOR BLADDER CANCER BY A PROTEIN SIGNATURE IN TISSUE SAMPLES

IPC classification:
G01N 33/574
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Institut Curie
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12797167

SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS

IPC classification:
A61P 7/00, A61P 29/00, A61P 35/00, A61P 35/02, A61P 37/00, A61P 37/08, A61P 43/00, C07D 471/04, A61K 31/4985, A61K 31/5375, A61K 31/553
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
The patent has been granted
EP12729587

COMPOSITION COMPRISING AN ONION EXTRACT AND LIPOSOMES

IPC classification:
A61K 9/00, A61K 9/06, A61K 9/127
Applicant:
Merz Pharma GmbH & Co. KGaA
Applicant:
Air Products and Chemicals Inc
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP12173644

Means and methods for proSP-B based diagnosis of alveolar damage in pulmonary hypertension patients

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION REFUSED
EP12173646

Means and methods for proSP-B based diagnosis of pulmonary congestion in ACS patients

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION REFUSED
EP12817923

PLANT TRANSFORMATION METHOD

IPC classification:
C12N 15/82, C12N 15/67, A01H 1/00, A01H 5/00
Applicant:
BASF Plant Science Company GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12735418

HUMAN RESPIRATORY SYNCYTIAL VIRUS VACCINE

IPC classification:
B82Y 99/00, A61K 39/155
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12817129

USE OF IL-12 TO GENERATE ENDOGENOUS ERYTHROPOIETIN

IPC classification:
A61K 39/395
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12172376

sFlt-1 based diagnosis and monitoring of stroke patients

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12163575

Pro SP-B and NT-proBNP based diagnosis in patients with pneumonia

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12742873

ALTERATION OF PROTEOLYTIC CLEAVAGE OF BOTULINUM NEUROTOXINS

IPC classification:
C07K 14/435, A61K 38/00
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12173564

TnT and H-FABP for diagnosis of cardiac damage in infection

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12825300

HERPES SIMPLEX VIRUS NANOEMULSION VACCINE

IPC classification:
A61K 39/21
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12828245

WATER-BASED POLYMER EMULSIONS FOR OPAQUE FILMS AND COATINGS APPLICATIONS

IPC classification:
C08F 20/10, C08J 3/03, C08J 3/16, C08J 5/18, C09D 4/02
Applicant:
BASF SE
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12827163

WATER-BASED POLYMER EMULSIONS FOR OPAQUE FILMS AND COATINGS APPLICATIONS ON FLEXIBLE SUBSTRATES

IPC classification:
C08F 20/10, C08J 3/03, C08J 3/16, C08J 5/18, C09D 4/02
Applicant:
BASF SE
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12829559

NANOEMULSION RESPIRATORY SYNCYTIAL VIRUS (RSV) SUBUNIT VACCINE

IPC classification:
A61K 39/155
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12832241

MEANS AND METHODS FOR ASSESSING HEMATOPOIETIC TOXICITY

IPC classification:
G01N 33/50
Applicant:
BASF SE
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12831825

MEANS AND METHODS FOR ASSESSING KIDNEY TOXICITY

IPC classification:
G01N 33/53
Applicant:
BASF SE
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12831339

MEANS AND METHODS FOR ASSESSING GONADAL TOXICITY

IPC classification:
G01N 33/49, G01N 33/64, G01N 33/68, G01N 33/70, G01N 33/74, G01N 33/92
Applicant:
BASF SE
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP12759094

B7-H6 THERAPEUTICALLY ACTIVE MONOCLONAL ANTIBODY AGAINST B7-H6 POLYPEPTIDE

IPC classification:
C07K 16/28, G01N 33/483
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP12758452

MEANS AND METHODS FOR TREATING AND/OR PREVENTING NATURAL AHR LIGAND-DEPENDENT CANCER

IPC classification:
A61P 35/00, A61K 31/00, A61K 31/352, A61K 31/415
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP12153477

Method for variant differentiation utilizing a pyrosequencing dispensation order

IPC classification:
C12Q 1/68
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13155742

The signature of Wnt/ss-catenin signaling in Cancer

IPC classification:
C12Q 1/68
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12163606

Inhibitors of Receptor for Advanced Glycation-End products (RAGE) for use in treating and/or preventing inflammation- and/or damage-induced cancer

IPC classification:
A61P 35/00, A61K 38/17
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Applicant:
Hebrew University of Jerusalem
Applicant:
Hadassah Medical Organization
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION REFUSED
EP12841511

PLANTS HAVING ENHANCED YIELD-RELATED TRAITS AND PRODUCING METHODS THEREOF

IPC classification:
C12N 15/82, C12N 15/63, A01H 5/00
Applicant:
BASF Plant Science Company GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP14162687

Modified AAV capsid polypeptides

IPC classification:
C12N 15/864
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP11839758

PLANTS HAVING ENHANCED YIELD-RELATED TRAITS AND METHOD FOR MAKING THE SAME

IPC classification:
C12N 15/82, C07K 14/415
Applicant:
BASF Plant Science Company GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP13158379

Loop-shRNAs

IPC classification:
C12N 15/113, A61K 31/713
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13156342

Compounds for use in inhibiting HIV capsid assembly

IPC classification:
A61P 31/18, A61K 31/505, A61K 31/506
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Institute of Organic Chemistry and Biochemistry
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13156371

Compounds for use in inhibiting HIV capsid assembly

IPC classification:
A61P 31/18, A61K 31/517
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Institute of Organic Chemistry and Biochemistry
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805431

COMPOSITION FOR TREATING OR PREVENTING NEURODEGENERATIVE DISORDERS

IPC classification:
A61P 25/28, A61K 36/23, A61K 36/59
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12784579

DYNAMIC OF SFLT-1 OR ENDOGLIN/PLGF RATIO AS AN INDICATOR FOR IMMINENT PREECLAMPSIA AND/OR HELLP SYNDROME

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
The patent has been granted
EP12783603

NEUROTOXINS EXHIBITING SHORTENED BIOLOGICAL ACTIVITY

IPC classification:
C07K 14/33, C07K 14/435, C07K 14/47, C12N 5/00, A61K 38/00
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12781345

MODIFIED NEUROTOXINS WITH POLY-GLYCINE AND USES THEREOF

IPC classification:
C07K 14/33, A61K 35/56
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12773753

DRUG DELIVERY PARTICLES AND METHOD FOR PRODUCING SAME

IPC classification:
C12N 5/10, C12N 7/02, C12N 15/09, C12P 21/02, A61K 9/50, A61K 38/00
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP12835606

COMPOSITIONS AND METHODS FOR TOXIGENICITY TESTING

IPC classification:
C12Q 1/02, C12Q 1/68, C40B 30/06
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
The patent has been granted
EP12799110

DEVICE AND METHODS TO DIAGNOSE PANCREATIC CANCER

IPC classification:
G01N 33/574
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12183508

Means and methods applying sFlt-1/PlGF or Endoglin/PlGF ratio to rule-out onset of preeclampsia within a certain time period

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP12857452

BACTERIALLY DERIVED, INTACT MINICELLS FOR DELIVERY OF THERAPEUTIC AGENTS TO BRAIN TUMORS

IPC classification:
A61P 35/00, A61K 9/00
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP14178582

Use of biomarkers in monitoring a medication in a subject suffering from heart failure

IPC classification:
G01N 33/53, G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP12813047

SECOND GENERATION VIRUS-LIKE PARTICLES (VLP) FROM EPSTEIN-BARR VIRUSES FOR VACCINATION PURPOSES

IPC classification:
C12N 7/00, C12N 15/86, A61K 39/12
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12806438

HISTONE DEACETYLASE 10-INHIBITOR CO-TREATMENT IN CANCER

IPC classification:
G01N 33/574, A61K 31/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12813362

SELECTIVE INHIBITION OF PHOSPHOENOLPYRUVATE CARBOXYLASES OF C4 PLANTS

IPC classification:
A01N 37/04, A01N 37/38, A01N 37/40, A01N 43/16, A01N 43/42, A01N 43/88, A01P 13/00
Applicant:
Heinrich Heine University of Dusseldorf (Heinrich-Heine-Universität Düsseldorf)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12801163

MITIGATION OF CUTANEOUS INJURY WITH IL-12

IPC classification:
A61P 17/02, C12P 21/04, A61K 9/00, A61K 38/20
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP11829186

INHIBITOR OF EXPRESSION OF DOMINANTLY MUTATED GENE

IPC classification:
A61P 35/00, A61P 35/02, C12N 15/11, C12N 15/113, A61K 31/7105
Applicant:
LSIP LLC
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Agent:
Cabinet Plasseraud
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13703092

BIOMARKER SET FOR IDENTIFYING A SEVERE FORM OF CANCER

IPC classification:
G01N 33/574
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13749515

MEANS AND METHODS FOR ASSESSING NEURONAL TOXICITY

IPC classification:
G01N 33/50
Applicant:
BASF SE
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13748922

MEANS AND METHODS FOR ASSESSING AN ENDOCRINE DISEASE OR DISORDER

IPC classification:
G01N 33/50
Applicant:
BASF SE
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12191981

NTproBNP and cTnT based therapy guidance in heart failure

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13706944

HBV IMMUNOCOMPLEXES FOR RESPONSE PREDICTION AND THERAPY MONITORING OF CHRONIC HBV PATIENTS

IPC classification:
G01N 33/576, G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Academic Medical Center at the University of Amsterdam (Academisch Medisch Centrum Amsterdam)
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13174242

Means and methods for universal calibration of anti-Factor Xa tests

IPC classification:
G01N 33/86, A61K 38/48
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION REFUSED
EP12796191

NUCLEASE FUSION PROTEIN AND USES THEREOF

IPC classification:
C12N 15/62
Applicant:
BASF Plant Science Company GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13709069

MEANS AND METHODS FOR THE DETERMINATION OF (D)-2-HYDROXYGLUTARATE (D2HG) OR (D)-2-HYDROXYADIPIC ACID

IPC classification:
C12Q 1/00
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13174901

Method for producing a drought and salt tolerant plant

IPC classification:
C12N 15/82
Applicant:
University of Bonn (Rheinische Friedrich-Wilhelms-Universität Bonn)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13707663

MEANS AND METHODS FOR DETERMINING NEUROTOXIN ACTIVITY BASED ON A MODIFIED LUCIFERASE

IPC classification:
C07K 14/00, C12Q 1/37, C12Q 1/66, G01N 33/542
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
The patent has been granted
EP13707185

COMPATIBLE SOLUTE ECTOINE AS WELL AS DERIVATIVES THEREOF FOR ENZYME STABILIZATION

IPC classification:
C12Q 1/32
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Applicant:
Roche Diabetes Care GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP13758490

MEANS AND METHODS FOR ASSESSING HYPERTHYROIDISM

IPC classification:
A61B 5/00, A61B 19/00
Applicant:
BASF SE
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP12173196

Composition for treating lymphedema

IPC classification:
A61P 7/10, A61K 36/11, A61K 36/15, A61K 36/185, A61K 36/30, A61K 36/31, A61K 36/80, A61K 36/50, A61K 36/515, A61K 36/52, A61K 36/56, A61K 36/808, A61K 36/90
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12814373

PLANTS HAVING ENHANCED YIELD-RELATED TRAITS AND A METHOD FOR MAKING THE SAME

IPC classification:
C12N 15/82, C07K 14/405
Applicant:
BASF Plant Science Company GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12173200

Composition for treating wound healing

IPC classification:
A61P 17/02, A61K 36/11, A61K 36/15, A61K 36/185, A61K 36/30, A61K 36/50, A61K 36/515, A61K 36/52, A61K 36/56, A61K 36/90
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13713122

B-CELL RECEPTOR COMPLEX BINDING PROTEINS CONTAINING T-CELL EPITOPES

IPC classification:
C07K 14/05, C07K 16/28, C07K 19/00, A61K 39/00
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12872506

NEURONAL CULTURE MEDIUM AND METHOD FOR PRODUCING IN VIVO-LIKE AND ENHANCED SYNAPTOGENESIS NEURON MODEL

IPC classification:
C12N 1/00, C12N 5/0793
Applicant:
Okinawa Institute of Science and Technology Graduate University
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12724645

METHODS FOR DIAGNOSING MULTIPLE SCLEROSIS

IPC classification:
G01N 33/564
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP13181687

Marker for statin treatment stratification in heart failure

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13187133

Non-ribosomal protein synthesis pigment fusion peptides

IPC classification:
C07K 14/435
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION REFUSED
EP13187966

ProSP-B for interstitial lung diseases

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP15151650

Means and methods for metabolic differentiation of non-alcoholic steatohepatitis from liver disease

IPC classification:
G01N 33/68, G06F 19/00
Applicant:
Universitätsklinikum Schleswig-Holstein
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
The patent has been granted
EP13805173

SUPPORT FOR ANTIBODY PURIFICATION, MANUFACTURING METHOD FOR SAME, AND APPLICATION FOR SAME

IPC classification:
C07K 1/22, C07K 14/31, C07K 17/00, G01N 30/88, G01N 33/53, G01N 37/00
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13189926

Differential diagnosis of acute dyspnea based on C-terminal proSP-B, KL-6 and BNP-type peptides

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13729369

COMPOSITION FOR TREATING WOUND HEALING

IPC classification:
A61P 17/02, A61K 36/02, A61K 36/11, A61K 36/15, A61K 36/185, A61K 36/30, A61K 36/50, A61K 36/515, A61K 36/52, A61K 36/56, A61K 36/90
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
The patent has been granted
EP13729714

COMPOSITION FOR TREATING LYMPHEDEMA

IPC classification:
A61P 7/10, A61K 36/11, A61K 36/15, A61K 36/185, A61K 36/30, A61K 36/31, A61K 36/80, A61K 36/50, A61K 36/515, A61K 36/52, A61K 36/56, A61K 36/808, A61K 36/90
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
The patent has been granted
EP13732878

MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD

IPC classification:
G01N 33/50
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13731813

METHODS FOR IDENTIFYING DIABETES DRUGS

IPC classification:
G01N 33/50
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP13788941

BIOMARKERS TO IMPROVE PREDICTION OF HEART FAILURE RISK

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Applicant:
The University of North Carolina at Chapel Hill
Applicant:
Baylor College of Medicine
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12736407

PLANTS HAVING ENHANCED YIELD-RELATED TRAITS AND METHOD FOR MAKING THE SAME

IPC classification:
C12N 15/82, C07K 14/415
Applicant:
BASF Plant Science Company GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15167547

METHODS FOR ANALYZING POLAR METABOLITES OF THE ENERGY METABOLISM

IPC classification:
G01N 30/02, G01N 33/50
Applicant:
BASF Plant Science Company GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP11850650

MEANS AND METHOD FOR PREDICTING DIABETES

IPC classification:
G01N 33/50, G01N 33/53, G01N 33/68
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11824596

FUSED HETEROARYLS AND THEIR USES

IPC classification:
A61P 35/00, C07D 471/04, C07D 471/14, C07D 487/04, A61K 31/4375, A61K 31/4745, A61K 31/4985
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14732895

MEANS AND METHODS FOR UNIVERSAL CALIBRATION OF ANTI-FACTOR Xa TESTS

IPC classification:
G01N 33/86, A61K 38/48
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP11793827

COMPETITIVE BIOSENSOR HAVING ELEVATED SENSITIVITY

IPC classification:
G01N 33/542, G01N 33/543, G01N 33/66
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12158286

Compatible solute ectoine as well as derivatives thereof for enzyme stabilization

IPC classification:
C12Q 1/32
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION REFUSED
EP12157663

Means and methods for the determination of (D)-2-hydroxyglutarate (D2HG)

IPC classification:
C12Q 1/00
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION REFUSED
EP11793841

USE OF HYDROGELS FOR BIOSENSORS HAVING ELEVATED SENSITIVITY

IPC classification:
G01N 33/53, G01N 33/543, G01N 33/66
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12736084

PROCESS FOR PRODUCTION OF NK-CELL-ENRICHED BLOOD PREPARATION

IPC classification:
A61P 31/10, A61P 31/12, A61P 35/00, A61P 37/04, C12N 5/0783, A61K 35/14, A61K 35/28
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11743231

Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure

IPC classification:
G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED
EP11767970

MEANS AND METHODS FOR DIAGNOSING CANCER USING AN ANTIBODY WHICH SPECIFICALLY BINDS TO BRAF V600E

IPC classification:
C07K 16/30, G01N 33/50, G01N 33/543, G01N 33/574, G01N 33/68
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11743526

SELECTIVE MANUFACTURE OF RECOMBINANT NEUROTOXIN POLYPEPTIDES

IPC classification:
C07K 14/33
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12742482

EXTERNAL SKIN PREPARATION

IPC classification:
A61Q 11/00, A61Q 19/00, A61Q 19/08, A61K 8/02, A61K 8/23, A61K 8/35, A61K 8/67, A61K 8/97
Applicant:
JX Nippon Oil & Energy Corporation
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12152603

Method for the differentiation of forward and backward heart failure

IPC classification:
G01N 33/68, G01N 33/74
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11821968

METHOD FOR PRODUCTION OF NOVEL DEGALACTOSYLATED GC GLOBULIN

IPC classification:
A61P 35/00, C07K 14/47, C12P 21/02, A61K 38/17
Applicant:
The University of Tokushima
Applicant:
Tokyo University of Science
Agent:
Alexander Dick, Herzog Fiesser & Partner Patentanwälte PartG mbB
Status:
PATENT GRANTED

Please Sign in to use this feature